SciELO - Scientific Electronic Library Online

 
vol.39 número3Características clínicas e demográficas de crianças hospitalizadas com infecção por SARS CoV-2Resultados obstétricos e perinatais da doença materna COVID-19. Estudo de casos e controles índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Links relacionados

Compartilhar


Revista Médica del Uruguay

versão impressa ISSN 0303-3295versão On-line ISSN 1688-0390

Resumo

CAMEJO, Natalia et al. Impact of the COVID-19 Pandemic on diagnosis and treatment of breast cancer in patients assisted at Clinicals Hospital Breast Unit. Rev. Méd. Urug. [online]. 2023, vol.39, n.3, e203.  Epub 01-Set-2023. ISSN 0303-3295.  https://doi.org/10.29193/rmu.39.3.3.

Introduction:

the COVID-19 health crisis had a significant impact on the management of various pathologies, including cancer. To reduce the risk of contracting SARS-CoV-2, the number of consultations was reduced, leading to increased morbidity and mortality rates for other pathologies, which has been referred to as the “second pandemic.” Objective: The aim of this study is to describe the clinical activity of the Breast Unit (BU) during the period March 2020-2022 and compare it with the activity during the period March 2019-2021.

Objective:

the aim of this study is to describe the clinical activity of the Breast Unit (BU) during the period March 2020-2022 and compare it with the activity during the period March 2019-2021.

Method:

retrospective observational study including patients attending the BU during the period March 2019-2022.

Results:

in the year before the pandemic, 30 new patients were assisted. Regarding the time between anatomopathological diagnosis and the initiation of the first treatment: in 73.3% of cases, it was ≤ 2 months, 16.6% > 2 months and ≤ 4 months, and in 10%, it was > 4 months. During the pandemic, 50 new patients were assisted, representing a decrease of approximately 16.6% in the number of new patients attended. Regarding the time between anatomopathological diagnosis and the initiation of the first treatment: in 41% of cases, it was ≤ 2 months, 33% > 2 months and ≤ 4 months, and in 25%, it was > 4 months.

Conclusion:

although the BU managed to maintain its clinical activity and continuity of most treatments during the COVID pandemic, there was a reduction in the number of patients referred to the service by approximately 16.6% and an increase in the time elapsed between diagnosis and the initiation of the first treatment.

Palavras-chave : COVID-19; Breast cancer; Medical Care.

        · resumo em Português | Espanhol     · texto em Espanhol     · Espanhol ( pdf )